Yingxi Lin.

Yingxi Li

Professor of psychiatry and neuroscience
University of Texas Southwestern Medical Center

Yingxi Li is professor of psychiatry and neuroscience, and chief of the Psychiatry Neuroscience Research Division at University of Texas Southwestern Medical Center. Her research focuses on uncovering molecular and circuit mechanisms in neurodevelopment, memory formation and neuropsychiatric conditions. Employing a broad array of multidisciplinary experimental techniques, work in her lab spans analyses from the genomic and molecular level to synapse, circuit and whole-animal behavioral levels.

Originally from China, Lin studied engineering physics at Tsinghua University and received her Ph.D. in biophysics from Harvard University. She conducted her postdoctoral research under Michael Greenberg at Harvard Medical School. She was assistant professor from 2009 to 2015 and associate professor from 2015 to 2018 at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology. Prior to her current role, she was full professor and director of the Neuroscience Graduate Program at SUNY Upstate Medical University.

Explore more from The Transmitter

Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion

The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.

By Sarah DeWeerdt
30 April 2026 | 0 min watch
Conference attendees

Reporter’s notebook: Highlights from INSAR 2026

At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.

By Diana Kwon
30 April 2026 | 6 min read
Illustration of hand with letter.

Scientists push back against stricter European Research Council grant application rules

In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”

By Lauren Schenkman
29 April 2026 | 5 min read